Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis

被引：0
作者：
Patricia Pozo-Rosich
Karen H. Samaan
Todd J. Schwedt
Robert A. Nicholson
Mallikarjuna Rettiganti
Eric M. Pearlman
机构：
[1] Vall d’Hebron University Hospital,Headache Unit, Neurology Department
[2] Vall d’Hebron Research Institute,Headache and Neurological Pain Research Group, Department de Medicine
[3] Universitat Autònoma de Barcelona,undefined
[4] Eli Lilly and Company,undefined
[5] LTC-South,undefined
[6] Mayo Clinic,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Chronic; Efficacy; Episodic; Galcanezumab; Migraine; Wear off;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3154 / 3165
页数：11
相关论文
共 24 条
[11]   Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE-1 and EVOLVE-2 [J].
Macgregor, E. Anne ;
Okonkwo, Rose ;
Detke, Holland C. ;
Polavieja, Pepa ;
Fernandes, Maria S. ;
Pavlovic, Jelena M. .
HEADACHE, 2024, 64 (02) :179-187
[12]   Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study [J].
Wang, Shuu-Jiun ;
Kim, Byung-Kun ;
Wang, Hebo ;
Zhou, Jiying ;
Wan, Qi ;
Yu, Tingmin ;
Lian, Yajun ;
Arkuszewski, Michal ;
Ecochard, Laurent ;
Snellman, Josefin ;
Wen, Shihua ;
Yin, Fangfang ;
Li, Zheng ;
Su, Wendy ;
Yu, Shengyuan .
HEADACHE, 2025, 65 (01) :143-152
[13]   Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis [J].
Jessica Ailani ;
Jeffrey Scott Andrews ;
Antje Tockhorn-Heidenreich ;
Richard Wenzel ;
Mallikarjuna Rettiganti .
Advances in Therapy, 2022, 39 :4544-4555
[14]   Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis [J].
Ailani, Jessica ;
Andrews, Jeffrey Scott ;
Tockhorn-Heidenreich, Antje ;
Wenzel, Richard ;
Rettiganti, Mallikarjuna .
ADVANCES IN THERAPY, 2022, 39 (10) :4544-4555
[15]   100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies [J].
Rosen, Noah ;
Pearlman, Eric ;
Ruff, Dustin ;
Day, Kathleen ;
Nagy, Abraham Jim .
HEADACHE, 2018, 58 (09) :1347-1357
[16]   Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study [J].
Takeshima, Takao ;
Doi, Hikaru ;
Ooba, Satomi ;
Tanji, Yuka ;
Ozeki, Akichika ;
Komori, Mika .
NEUROLOGY AND THERAPY, 2024, 13 (03) :697-714
[17]   Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies [J].
Nichols, Russell ;
Doty, Erin ;
Sacco, Sara ;
Ruff, Dustin ;
Pearlman, Eric ;
Aurora, Sheena K. .
HEADACHE, 2019, 59 (02) :192-204
[18]   Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials [J].
Tepper, Stewart J. ;
Ashina, Messoud ;
Reuter, Uwe ;
Hallstroem, Yngve ;
Broessner, Gregor ;
Bonner, Jo H. ;
Picard, Hernan ;
Cheng, Sunfa ;
Chou, Denise E. ;
Zhang, Feng ;
Klatt, Jan ;
Mikol, Daniel D. .
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
[19]   Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies [J].
Smitherman, Todd A. ;
Tietjen, Gretchen E. ;
Schuh, Kory ;
Skljarevski, Vladimir ;
Lipsius, Sarah ;
D'Souza, Deborah N. ;
Pearlman, Eric M. .
HEADACHE, 2020, 60 (10) :2202-2219
[20]   Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache [J].
Andrews, J. Scott ;
Kudrow, David ;
Rettiganti, Mallikarjuna ;
Oakes, Tina ;
Bardos, Jennifer N. ;
Wenzel, Richard ;
Kuruppu, Dulanji K. ;
Gaul, Charly ;
Martinez, James M. .
JOURNAL OF PAIN RESEARCH, 2021, 14 :2059-2070
123